Placing the highest value on human capital.

From our inception in 2008, every hiring decision, strategic partnership, and engagement with external policy makers, clients, and investors has been driven by a commitment to the highest ethical standards, deep mutual respect, and a spirit of collaboration.

Recombinetics has strategically built our organization around three core markets—biomedical research, regenerative medicine, and a safe, abundant food supply. Our business platforms continue to progress supported by an expert internal science team, proven executive team, and an array of noted advisors, partners and specialized staff.

our leadership

Rocco Morelli

Rocco Morelli

Chief executive officer
Dan Carlson

Dan Carlson, Ph.D.

Chief Scientific Officer and SVP of Research & Development

Tad Sonstegard, Ph.D.

Chief Executive & Scientific Officer  |  Acceligen
Adrienne Watson

Adrienne Watson, Ph.D.

chief science officer  |  therillume

William Haupt, CPA

VP of Finance

Sabreena Larson, M.S.

Chief Operations Officer

Jarryd Campbell, Ph.D.

Head of platform development

Derek Korpela, Ph.D.

Director of Preclinical Services and Research Veterinarian

Dennis Webster

Director of Cell Culture

our board


Tim Clarkson

Peter Hajas

David Laraespada

David Largaespada

Marylinn Munson

Shane Dore

Your investment can help us change the world.

Reach out today for information on how you can make a difference.